Search This Blog

Monday, June 11, 2018

Biohaven started at buy by Cantor


Biohaven Pharmaceutical initiated with an Overweight at Cantor Fitzgerald. Cantor initiated Biohaven Pharmaceuticals with a Overweight and $42 price target.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)